Literature DB >> 7690967

T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route.

T Lehner1, R Brookes, C Panagiotidi, L Tao, L S Klavinskis, J Walker, P Walker, R Ward, L Hussain, J H Gearing.   

Abstract

Transmission of human immunodeficiency virus (HIV) in North America and Europe occurs most commonly through the rectal mucosa during homosexual intercourse. The simian immunodeficiency virus (SIV) macaque model has been used to investigate rectal immunization. The vaccine used was a recombinant SIV gag p27 expressed as hybrid Ty virus-like particles (Ty-VLP). Sequential ororectal (OR) mucosal immunization was compared with i.m. immunization. Whereas both routes of immunization induced serum IgA and IgG p27 antibodies, only OR immunization induced rectal secretory IgA antibodies. Specific CD4+ T-cell proliferative responses to stimulation with p27 were found after i.m. immunization only in the blood and spleen, but after OR immunization they were found in the internal iliac and inferior mesenteric lymph nodes in addition to the blood and spleen. T-cell epitope mapping of the proliferative responses of short-term cell lines (STCLs) grown from peripheral blood or lymphoid cells revealed a major epitope within the polypeptide 121-150 after either route of immunization. Two minor T-cell epitopes were found within peptide 41-80 in STCLs from splenic and circulating cells. B-cell epitope mapping of serum or biliary IgA and IgG antibodies revealed two overlapping or adjacent immunodominant epitopes to the T-cell epitopes within the polypeptides 121-170 and 51-90. The results suggest that rectal augmented by oral immunization with a recombinant particulate antigen in nonhuman primates elicits secretory IgA and to a lesser extent IgG responses in the draining lymph nodes and the rectal mucosa, whereas systemic immunization targets predominantly splenic and circulating T- and B-cell responses. These findings may have important implications in the strategy of designing vaccines in prevention of homosexual transmission of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690967      PMCID: PMC47413          DOI: 10.1073/pnas.90.18.8638

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

Review 2.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

3.  HIV infection of rectal mucosa.

Authors:  J M Mathijs; M Hing; J Grierson; D E Dwyer; C Goldschmidt; D A Cooper; A L Cunningham
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

4.  Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.

Authors:  K H Mayer; D Ayotte; J E Groopman; A M Stoddard; M Sarngadharan; R Gallo
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

5.  Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

Authors:  N L Letvin; M D Daniel; P K Sehgal; R C Desrosiers; R D Hunt; L M Waldron; J J MacKey; D K Schmidt; L V Chalifoux; N W King
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

6.  Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.

Authors:  J A Mattingly; B H Waksman
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

Review 7.  Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features.

Authors:  J A Levy; L S Kaminsky; W J Morrow; K Steimer; P Luciw; D Dina; J Hoxie; L Oshiro
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

8.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

9.  HTLV-III in the semen and blood of a healthy homosexual man.

Authors:  D D Ho; R T Schooley; T R Rota; J C Kaplan; T Flynn; S Z Salahuddin; M A Gonda; M S Hirsch
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

10.  Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus.

Authors:  A Adachi; S Koenig; H E Gendelman; D Daugherty; S Gattoni-Celli; A S Fauci; M A Martin
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

View more
  7 in total

1.  Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.

Authors:  M Lagranderie; A M Balazuc; B Gicquel; M Gheorghiu
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

Authors:  P A Kozlowski; S Cu-Uvin; M R Neutra; T P Flanigan
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

3.  Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.

Authors:  T Lehner; L Tao; C Panagiotidi; L S Klavinskis; R Brookes; L Hussain; N Meyers; S E Adams; A J Gearing; L A Bergmeier
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.

Authors:  T Lehner; Y Wang; M Cranage; L Tao; E Mitchell; C Bravery; C Doyle; K Pratt; G Hall; M Dennis; L Villinger; L Bergmeier
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

Review 5.  Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines.

Authors:  J Mestecky; S Jackson
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

Review 6.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

7.  Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.

Authors:  I Takahashi; H Kiyono; R J Jackson; K Fujihashi; H F Staats; S Hamada; J D Clements; K L Bost; J R McGhee
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.